Medicare Enrolled

Dr. Keyur Patel, M.D.

Neurology · Clearwater, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1417 S BELCHER RD STE C, Clearwater, FL 33764
7274433295
In practice since 2013 (12 years)
NPI: 1548606460 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Keyur Patel is a neurology in Clearwater, FL, with 12 years in practice. Based on federal Medicare data, Dr. Patel performed 86,440 Medicare services across 659 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $23,114 from 62 pharmaceutical and/or device companies across 916 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 1% volume in FL$ $23,114 industry payments

Medicare Practice Summary

Medicare Utilization ↗
86,440
Medicare services
Top 1% in FL for neurology
659
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,203 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit85,200$5$9
Office visit, established patient (20-29 min)404$64$99
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face256$127$212
Office visit, established patient (30-39 min)254$90$147
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box131$164$250
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle94$57$96
Injection of anesthetic agent and/or steroid into upper neck and back of head nerve40$46$140
New patient office visit, complex (60-74 min)26$153$284
New patient office visit (45-59 min)22$122$226
Office visit, established patient, complex (40-54 min)13$108$198
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,114
Total received (2018-2024)
Avg $3,302/year across 7 years
Top 14% in FL for neurology
62
Companies
916
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,055 (73.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,059 (26.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,348
2023
$4,493
2022
$3,862
2021
$2,420
2020
$1,575
2019
$308
2018
$108

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$7,288
UCB, Inc.
$1,285
SK Life Science, Inc.
$1,054
Allergan, Inc.
$1,003
JAZZ PHARMACEUTICALS INC.
$829
Teva Pharmaceuticals USA, Inc.
$808
Lilly USA, LLC
$726
Eisai Inc.
$706
PFIZER INC.
$683
Amgen Inc.
$660
Lundbeck LLC
$653
Biohaven Pharmaceuticals, Inc.
$624
Otsuka America Pharmaceutical, Inc.
$523
UPSHER-SMITH LABORATORIES LLC
$490
Neurocrine Biosciences, Inc.
$424
ARGENX US, INC.
$420
IMPEL PHARMACEUTICALS INC.
$392
AbbVie Inc.
$341
Avanir Pharmaceuticals, Inc.
$337
Biohaven Pharmaceutical Holding Company Ltd.
$314
Sumitomo Pharma America, Inc.
$277
Neurelis, Inc.
$231
EISAI INC.
$213
Upsher-Smith Laboratories LLC
$185
SCILEX PHARMACEUTICALS INC.
$168
Merz Pharmaceuticals, LLC
$160
Sunovion Pharmaceuticals Inc.
$146
Almatica Pharma LLC
$142
Amneal Pharmaceuticals LLC
$140
Abbott Laboratories
$123
CATALYST PHARMACEUTICALS, INC.
$112
Kyowa Kirin, Inc.
$110
Nevro Corp.
$104
Acorda Therapeutics, Inc
$97
Supernus Pharmaceuticals, Inc.
$94
ARBOR PHARMACEUTICALS, INC.
$89
Currax Pharmaceuticals LLC
$88
GE HealthCare
$78
Allergan Inc.
$78
IDORSIA PHARMACEUTICALS US INC
$75
Scilex Pharmaceuticals Inc.
$67
Harmony Biosciences Llc
$65
Merck Sharp & Dohme LLC
$64
Collegium Pharmaceutical, Inc.
$64
Azurity Pharmaceuticals, Inc.
$60
PORTOLA PHARMACEUTICALS, LLC
$58
MDD US Operations, LLC
$55
Tonix Medicines, Inc.
$48
Catalyst Pharmaceuticals, Inc.
$43
Adamas Pharmaceuticals, Inc.
$41
Harmony Biosciences LLC
$39
Jazz Pharmaceuticals Inc.
$35
Merck Sharp & Dohme Corporation
$29
ShockWave Medical, Inc
$29
Takeda Pharmaceuticals U.S.A., Inc.
$25
LivaNova USA, Inc.
$22
REVANCE THERAPEUTICS, INC.
$20
Boston Scientific Corporation
$19
AstraZeneca Pharmaceuticals LP
$19
Alexion Pharmaceuticals, Inc.
$17
Inspire Medical Systems, Inc.
$16
Biogen, Inc.
$13
Top 3 companies account for 41.6% of total payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · AMYVID · ANDEXXA · APTIOM · AUSTEDO · Aimovig · Austedo XR · BELSOMRA · BOTOX · Briviact · COMIRNATY · CONTRAVE · CREXONT · DAXXIFY · DUOPA · Dayvigo · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GOCOVRI · GRALISE · HORIZANT · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · KISUNLA · Leqembi · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · ONZETRA XSAIL · Omnia · Ongentys · PAXLOVID · Proclaim Family of SCS IPGs · Prodigy Family of SCS IPGs · QULIPTA · QUVIVIQ · REXULTI · RYTARY · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SOLIRIS · SUNOSI · Senza · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · VALTOCO · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XCOPRI · XYREM · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $27 per 100 Medicare services performed
Looking for a neurology in Clearwater?
Compare neurologys in the Clearwater area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
170
Per 100K population
17.7
County median income
$70,293
Nearest hospital
WINDMOOR HEALTHCARE OF CLEARWATER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 14%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Patel performed 85,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $23,114 from 62 companies across 916 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other neurologys in Clearwater?
Dr. Patel's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →